Ambient Particulate Matter Induces In Vitro Toxicity to Intestinal Epithelial Cells without Exacerbating Acute Colitis Induced by Dextran Sodium Sulfate or 2,4,6-Trinitrobenzenesulfonic Acid.

Autor: Chang C; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.; Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA., Louie A; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.; Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA., Zhou Y; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; West China Medical Center, Sichuan University, Chengdu 610017, China., Gupta R; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.; Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA., Liang F; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Xanthou G; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Ereso J; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Koletic C; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Yang JC; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Sedighian F; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Lagishetty V; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Arias-Jayo N; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Altuwayjiri A; USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA.; Department of Civil and Environmental Engineering, College of Engineering, Majmaah University, Al-Majmaah 11952, Saudi Arabia., Tohidi R; USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA.; Air Quality Planning and Science Division, California Air Resources Board, 4001 Iowa Avenue, Riverside, CA 92507, USA., Navab M; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Reddy ST; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; West China Medical Center, Sichuan University, Chengdu 610017, China.; Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095, USA., Sioutas C; USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA., Hsiai T; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Henry Samueli School of Engineering, University of California Los Angeles, Los Angeles, CA 90095, USA., Araujo JA; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.; Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA., Jacobs JP; Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA.; Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.; Goodman-Luskin Microbiome Center, University of California Los Angeles, Los Angeles, CA 90095, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 29; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 29.

TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.

Autor: Theofani E; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 1st Department of Respiratory Medicine, Medical School, 'Sotiria' Athens Chest Diseases Hospital, National Kapodistrian University of Athens, Athens, Greece., Semitekolou M; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Samitas K; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 7th Respiratory Clinic and Asthma Center of the 'Sotiria' Athens Chest Hospital, Athens, Greece., Mais A; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Galani IE; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, BRFAA, Athens, Greece., Triantafyllia V; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, BRFAA, Athens, Greece., Lama J; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Morianos I; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Stavropoulos A; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, BRFAA, Athens, Greece., Jeong SJ; Department of Medicine, Cardiovascular Division, and Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Andreakos E; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, BRFAA, Athens, Greece., Razani B; Department of Medicine, Cardiovascular Division, and Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.; John Cochran VA Medical Center, St. Louis, Missouri, USA., Rovina N; 1st Department of Respiratory Medicine, Medical School, 'Sotiria' Athens Chest Diseases Hospital, National Kapodistrian University of Athens, Athens, Greece., Xanthou G; Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

Publikováno v: Allergy [Allergy] 2022 Jul; Vol. 77 (7), pp. 2131-2146. Date of Electronic Publication: 2022 Jan 25.

Correction: Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD) (Molecular Psychiatry, (2021), 26, 4, (1248-1263), 10.1038/s41380-020-0651-6)

Autor: Gampierakis, I.-A. Koutmani, Y. Semitekolou, M. Morianos, I. Polissidis, A. Katsouda, A. Charalampopoulos, I. Xanthou, G. Gravanis, A. Karalis, K.P.

An amendment to this paper has been published and can be accessed via a link at the top of the paper. © 2020, Springer Nature Limited.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::113b6ad33871bc1a790f6000c3bb7d52
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997124

Advantages and Limitations of the Neonatal Immune System

Autor: Tsafaras, G.P. Ntontsi, P. Xanthou, G.

During early post-natal life, neonates must adjust to the transition from the sheltered intra-uterine environment to the microbe-laden external world, wherein they encounter a constellation of antigens and the colonization by the microbiome. At this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::25c9b61034a662ab177c6545aa202cab
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104841

Supplementary Material for: Activin-A Is a Pro-Inflammatory Regulator in Type-2-Driven Upper Airway Disease

Autor: Chaker, A.M., Zissler, U.M., Poulos, N., Wagenmann, M., Bas, M., Gürth, F., Xanthou, G., Schmidt-Weber, C.

Background: Allergic upper airway disease involves pro-inflammatory type-2 cytokines such as IL-5 and regulatory tissue repair mediators, in particular transforming growth factor (TGF)-β1. The TGF-β-superfamily member activin-A displays multiple bi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8dfadf230b52d4085d8b4b9ef7a02ee5